Yuan Cai Selected Research

Yuan Cai Research Topics

Disease

27	Neoplasms (Cancer) 11/2023 - 04/2013
9	Hypoxia (Hypoxemia) 04/2022 - 05/2017
6	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 03/2015
5	Infections 01/2023 - 11/2017
5	Lung Neoplasms (Lung Cancer) 11/2022 - 12/2018
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2013
4	Wounds and Injuries (Trauma) 01/2023 - 01/2017
4	Carcinogenesis 01/2022 - 12/2016
3	Inflammation (Inflammations) 04/2024 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2015
3	Cognitive Dysfunction 02/2019 - 09/2014
2	Schizophrenia (Dementia Praecox) 01/2024 - 01/2022
2	Leukostasis 01/2024 - 01/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2023
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2021
2	Adenocarcinoma of Lung 01/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Brain Injuries (Brain Injury) 10/2021 - 01/2017
2	Ischemic Stroke 10/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 10/2018
2	Reperfusion Injury 01/2021 - 10/2019
2	COVID-19 01/2021 - 01/2021
1	Arthritis (Polyarthritis) 04/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024
1	Obesity 04/2024
1	Spinal Cord Injuries (Spinal Cord Injury) 04/2024
1	Retinal Neovascularization 01/2024
1	Atrophy 01/2024
1	Dementia (Dementias) 01/2024
1	Intestinal Atresia 01/2024
1	Non-alcoholic Fatty Liver Disease 12/2023
1	Hyperlipidemias (Hyperlipidemia) 12/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2023
1	Chronic Hepatitis B 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023
1	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2023
1	Cicatrix (Scar) 01/2023

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2013
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2011
6	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2018
6	Long Noncoding RNAIBA 01/2023 - 01/2019
5	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2020
4	LanthanumIBA 02/2019 - 04/2013
3	Retinaldehyde (Retinal)IBA 01/2024 - 01/2017
3	CytokinesIBA 01/2023 - 04/2022
3	6-methyladenineIBA 01/2023 - 12/2020
3	Messenger RNA (mRNA)IBA 01/2023 - 04/2011
3	PlatinumIBA 09/2022 - 01/2019
3	Circular RNAIBA 01/2022 - 06/2021
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2024 - 01/2017
2	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2022
2	AlbuminsIBA 01/2022 - 01/2021
2	Competitive Endogenous RNAIBA 01/2022 - 01/2022
2	ZincIBA 01/2022 - 01/2013
2	Benzo(a)pyreneIBA 10/2021 - 04/2013
2	Epoxy Compounds (Epoxides)IBA 10/2021 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	EnzymesIBA 01/2021 - 01/2020
2	DioxygenasesIBA 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2020 - 01/2014
2	salicylhydroxamic acid (SHAM)IBA 10/2019 - 10/2018
2	Capsules (Microcapsules)IBA 01/2019 - 12/2015
2	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 12/2018 - 04/2013
2	ElementsIBA 01/2018 - 08/2016
2	lanthanum chlorideIBA 01/2017 - 04/2011
2	2-tert-butylhydroquinone (tert-butylhydroquinone)IBA 01/2017 - 10/2015
2	benzo(a)pyrene- 7,8- dihydrodiol- 9,10- epoxide- DNAIBA 12/2016 - 04/2013
2	Environmental CarcinogensIBA 08/2016 - 04/2013
2	EpitopesIBA 03/2015 - 01/2014
2	AluminumIBA 09/2014 - 01/2013
1	Complement C3 (C3 Complement)IBA 01/2024
1	Evans Blue (Blue, Evans)FDA Link 01/2024
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2024
1	Jiang-Zhi-NingIBA 12/2023
1	AdipokinesIBA 12/2023
1	tyloxapol FDA Link 12/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2023
1	Apolipoproteins E (ApoE)IBA 11/2023
1	ApolipoproteinsIBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Staphylococcal Protein A (Protein A)IBA 01/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023
1	InterferonsIBA 01/2023

Therapy/Procedure

8	Therapeutics 01/2023 - 10/2018
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 10/2019
2	Immunotherapy 11/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2020
2	Renal Dialysis (Hemodialysis) 01/2021 - 01/2019
1	Intravitreal Injections 01/2024
1	Parenteral Nutrition 01/2024
1	Oral Administration 12/2023
1	Transplantation 01/2023
1	Lipectomy (Liposuction) 01/2023
1	Gas Lasers 01/2023